CTRI/2019/03/017914
Active, not recruiting
未知
International Diabetes Management Practice Study - IDMPS wave8
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: E089- Diabetes mellitus due to underlying condition without complications
- Sponsor
- Sanofi India Limited
- Status
- Active, not recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Cross sectional phase
- •\- All male and female adults (with lower legal age limitations (country specific) diagnosed with type 1 or type 2 diabetes, visiting the physician during the recruitment period of the cross\-sectional study, up to the number of patients allocated to the physician.
- •\- Written informed consent
- •2\. Longitudinal phase
- •\- Each patient will be asked to enter into the 9\-month follow\-up period
Exclusion Criteria
- •1\. Cross sectional phase
- •\- Concomitant participation in a clinical trial.
- •\- Current temporary insulin therapy (eg, gestational diabetes, surgery, pancreas cancer)
- •2\. Longitudinal phase
- •\- Concomitant participation in clinical trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study of different methods of disease management done for Diabetic Patients with various methods of evaluation of Diabetes and Treatment patterns adapted by doctors.Health Condition 1: null- DiabetesHealth Condition 2: E088- Diabetes mellitus due to underlying condition with unspecified complicationsCTRI/2018/04/013100Sanofi India Limited8,426
Completed
Phase 4
IDMPS will be an international, multicenter, observational study with a cross-sectional study to assess current practices in the management in the patients with type 1 and type 2 diabetes mellitus non-interventional on therapeutic strategyHealth Condition 1: null- Type 1 and Type 2 Diabetes MellitusHealth Condition 2: E109- Type 1 diabetes mellitus without complicationsCTRI/2012/02/002407Sanofi Synthelabo I Ltd12,519
Completed
Not Applicable
Diabetes care Implementation StudyDiabetes Mellitus type two (DM2)Nutritional, Metabolic, EndocrineDiabetesISRCTN21523044niversity Medical Centre Utrecht (UMCU) (The Netherlands)3,500
Recruiting
Not Applicable
Multicenter Investigation for Diabetes mellitus in AtheroSclerosisPatients admitted to the participating institution for 1. Acute myocardial infarction within 24 hours after symptom onset 2. Angina pectoris requiring PCI 3. Heart failure 4. Atrial fibrillation undergoing catheter ablation 5. Cerebral infarction 6. Transient ischemic attackJPRN-UMIN000010039ational Cerebral and Cardiovascular Center5,000
Completed
Not Applicable
Diabetes UK StudyTopic: Diabetes Research NetworkSubtopic: Type 2Disease: Nephropathy, Cardiovascular disease, Hypertension, Dyslipidaemia, Diabetic Control, Multiple complicationsNutritional, Metabolic, EndocrineChronic kidney diseaseISRCTN85900874South Tees Hospitals NHS Foundation Trust (UK)600